Latest News & Updates of Loncom Pharma

Smoking remains one of the most significant public health challenges worldwide, contributing to millions of preventable deaths annually. Despite widespread awareness of the health risks associated with tobacco use, many smokers find it difficult to quit due to nicotine addiction and withdrawal symptoms. Fortunately, advances in pharmaceutical therapies have made smoking cessation more achievable. One of the most effective aids is varenicline tartrate, a prescription medication that has helped countless individuals overcome their nicotine dependence.

CPHI Shanghai 2025: Biocom Pharma management team led a strong sales delegation to this prestigious gathering. Our booth attracted numerous visitors, facilitating deep exchanges and collaborative discussions with industry peers, experts, and partners, culminating in a highly fruitful conclusion.

Shandong Loncom Pharmaceutical Co., Ltd. has achieved a major regulatory milestone by obtaining the Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its Sorafenib Tosylate active pharmaceutical ingredient (API). This accomplishment h

IntroductionIn the realm of pharmaceutical advancements, the development of effective and safe active pharmaceutical ingredients (APIs) is crucial for improving patient outcomes. Among the latest innovations, Linzagolix Choline has emerged as a promising API, particularly in the treatment of endomet